There is currently no evidence to guide decisions about discontinuing memantine. There is a need for further well‐designed RCTs, across a range of dementia ...

1 июн. 2018 г. · Abruptly stopping high-dose cholinesterase inhibitors is not recommended. Most clinical trials tapered these medications over 2 to 4 weeks.

It's important not to stop taking a medication without speaking to a doctor first, as this may make dementia symptoms worse.

11 окт. 2021 г. · Consider tapering the Cholinesterase Inhibitor first, and then memantine second. Or if time is short (e.g., patient is expected to stop ...

An abrupt cessation of memantine may result in discontinuation syndrome that can be distressing and result in decline of natural course.

For individuals with dementia, recommendations call for a 50% dose reduction every 4 weeks. Answer from: Radiation Oncologist at Academic Institution.

3 февр. 2021 г. · There is currently no evidence to guide decisions about discontinuing memantine. There is a need for further well-designed RCTs, across a range ...

17 янв. 2019 г. · To investigate the experiences and perspectives of carers and family members when antidementia medications (cholinesterase inhibitors and/or memantine) are ...

26 февр. 2024 г. · The decision to continue or stop medication in Alzheimer's disease should be one that is based on each individual's preferences and level of functioning.